164 related articles for article (PubMed ID: 22351488)
1. Declaring the existence of human germ-cell mutagens.
Demarini DM
Environ Mol Mutagen; 2012 Apr; 53(3):166-72. PubMed ID: 22351488
[TBL] [Abstract][Full Text] [Related]
2. A Return to the Origin of the EMGS: Rejuvenating the Quest for Human Germ Cell Mutagens and Determining the Risk to Future Generations.
Marchetti F; Douglas GR; Yauk CL
Environ Mol Mutagen; 2020 Jan; 61(1):42-54. PubMed ID: 31472026
[TBL] [Abstract][Full Text] [Related]
3. Approaches for identifying germ cell mutagens: Report of the 2013 IWGT workshop on germ cell assays(☆).
Yauk CL; Aardema MJ; Benthem Jv; Bishop JB; Dearfield KL; DeMarini DM; Dubrova YE; Honma M; Lupski JR; Marchetti F; Meistrich ML; Pacchierotti F; Stewart J; Waters MD; Douglas GR
Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():36-54. PubMed ID: 25953399
[TBL] [Abstract][Full Text] [Related]
4. Preconception exposures to potential germ-cell mutagens.
Draper G
Radiat Prot Dosimetry; 2008; 132(2):241-5. PubMed ID: 18977774
[TBL] [Abstract][Full Text] [Related]
5. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the induction of chromosomal aberrations and gene mutations in rodent germ cells.
Adler ID; Carere A; Eichenlaub-Ritter U; Pacchierotti F
Environ Res; 2007 May; 104(1):37-45. PubMed ID: 17052706
[TBL] [Abstract][Full Text] [Related]
8. Germ cell mutagens: risk assessment challenges in the 21st century.
Singer TM; Yauk CL
Environ Mol Mutagen; 2010; 51(8-9):919-28. PubMed ID: 20740630
[TBL] [Abstract][Full Text] [Related]
9. Practical issues on the application of the GHS classification criteria for germ cell mutagens.
Morita T; Hayashi M; Nakajima M; Tanaka N; Tweats DJ; Morikawa K; Sofuni T
Regul Toxicol Pharmacol; 2009 Oct; 55(1):52-68. PubMed ID: 19505521
[TBL] [Abstract][Full Text] [Related]
10. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in germ-cell mutagenesis and genetic risk.
Eichenlaub-Ritter U; Adler ID; Carere A; Pacchierotti F
Environ Res; 2007 May; 104(1):22-36. PubMed ID: 17156773
[TBL] [Abstract][Full Text] [Related]
12. New approaches to assessing the effects of mutagenic agents on the integrity of the human genome.
Elespuru RK; Sankaranarayanan K
Mutat Res; 2007 Mar; 616(1-2):83-9. PubMed ID: 17174354
[TBL] [Abstract][Full Text] [Related]
13. The comet assay as an indicator test for germ cell genotoxicity.
Speit G; Vasquez M; Hartmann A
Mutat Res; 2009; 681(1):3-12. PubMed ID: 18462987
[TBL] [Abstract][Full Text] [Related]
14. Transgenic lambda medaka as a new model for germ cell mutagenesis.
Winn RN; Majeske AJ; Jagoe CH; Glenn TC; Smith MH; Norris MB
Environ Mol Mutagen; 2008 Apr; 49(3):173-84. PubMed ID: 18213652
[TBL] [Abstract][Full Text] [Related]
15. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes.
Cimino MC
Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190
[TBL] [Abstract][Full Text] [Related]
16. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for screening for potential human germ cell mutagens: an ICPEMC Working Paper.
Bridges BA; Mendelsohn ML
Prog Clin Biol Res; 1986; 209B():51-65. PubMed ID: 3749105
[No Abstract] [Full Text] [Related]
18. Hazard identification: efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens.
Waters MD; Stack HF; Jackson MA; Bridges BA
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):61-72. PubMed ID: 8143649
[TBL] [Abstract][Full Text] [Related]
19. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens.
Ashby J; Waters MD; Preston J; Adler ID; Douglas GR; Fielder R; Shelby MD; Anderson D; Sofuni T; Gopalan HN; Becking G; Sonich-Mullin C
Mutat Res; 1996 Jun; 352(1-2):153-7. PubMed ID: 8676904
[TBL] [Abstract][Full Text] [Related]
20. Gender effects on the incidence of aneuploidy in mammalian germ cells.
Pacchierotti F; Adler ID; Eichenlaub-Ritter U; Mailhes JB
Environ Res; 2007 May; 104(1):46-69. PubMed ID: 17292877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
